The National Institutes of Health (NIH) recently announced a cap on reimbursements for indirect costs associated with grants, significantly affecting funding for research institutions. This change could result in over $100 million in losses for Harvard University alone, which relies heavily on NIH funding for various biomedical research areas. In response, multiple lawsuits have been filed to challenge this decision, and a federal judge has temporarily halted its implementation. Harvard's vice provost for research, John H. Shaw, elaborates on the importance of indirect costs in supporting the overall infrastructure required for conducting vital research.
The NIH's decision to cap indirect costs threatens significant funding for research institutions, potentially resulting in over $100 million in losses for Harvard alone.
Indirect costs cover necessary expenses that support research but are not directly tied to a specific project, such as institution infrastructure and overhead.
Collection
[
|
...
]